Marketing-authorisation holder · Canada
Juno Pharma Canada Inc.
44 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Canada
44 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 44
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ARGATROBAN FOR INJECTION100 mg / ml · Solution | Argatroban | Canada | Marketed | 2026 |
| BIMATOPROST RC0.01 % / w/v · Solution | Bimatoprost | Canada | Marketed | 2026 |
| CALCIUM CHLORIDE INJECTION USP100 mg / ml · Solution | Calcium chloride | Canada | Marketed | 1990 |
| CARBETOCIN INJECTION100 mcg / ml · Solution | Carbetocin | Canada | Marketed | 2020 |
| CARBOPROST TROMETHAMINE INJECTION USP250 mcg / ml · Solution | Carboprost | Canada | Marketed | 2024 |
| CASPOFUNGIN FOR INJECTION70 mg / vial · Powder For Solution | Caspofungin | Canada | Marketed | 2017 |
| CASPOFUNGIN FOR INJECTION50 mg / vial · Powder For Solution | Caspofungin | Canada | Marketed | 2017 |
| CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE2 mg / ml · Solution | Cisatracurium | Canada | Marketed | 2014 |
| CISATRACURIUM SINGLE DOSE2 mg / ml · Solution | Cisatracurium | Canada | Not marketed | 2014 |
| DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP100 mcg / ml · Solution | Dexmedetomidine | Canada | Marketed | 2019 |
| DEXMEDETOMIDINE HYDROCHLORIDE INJECTION400 mcg / 100 ml · Solution | Dexmedetomidine | Canada | Marketed | 2020 |
| DEXMEDETOMIDINE HYDROCHLORIDE INJECTION200 mcg / 50 ml · Solution | Dexmedetomidine | Canada | Marketed | 2020 |
| DEXRAZOXANE FOR INJECTION250 mg / vial · Powder For Solution | Dexrazoxane | Canada | Marketed | 2025 |
| EPTIFIBATIDE INJECTION0.75 mg / ml · Solution | Eptifibatide | Canada | Marketed | 2024 |
| EPTIFIBATIDE INJECTION2 mg / ml · Solution | Eptifibatide | Canada | Marketed | 2024 |
| ERTAPENEM FOR INJECTION1 g / vial · Powder For Solution | Ertapenem | Canada | Marketed | 2020 |
| HALOPERIDOL INJECTION5 mg / ml · Solution | Haloperidol | Canada | Marketed | 2011 |
| IPRATROPIUM BROMIDE AND SALBUTAMOL SULPHATE INHALATION SOLUTION0.5 mg / 2.5 ml + 2.5 mg / 2.5 ml · Solution | Ipratropium bromide, Salbutamol | Canada | Marketed | 2019 |
| KETOROLAC TROMETHAMINE INJECTION, USP30 mg / ml · Solution | Ketorolac | Canada | Marketed | 2016 |
| LEVOCARNITINE INJECTION200 mg / ml · Solution | Levocarnitine | Canada | Authorised | |
| LIDOCAINE HYDROCHLORIDE INJECTION10 mg / ml · Solution | Lidocaine | Canada | Marketed | 2024 |
| LIDOCAINE HYDROCHLORIDE INJECTION20 mg / ml · Solution | Lidocaine | Canada | Marketed | 2024 |
| METOPROLOL TARTRATE INJECTION USP1 mg / ml · Solution | Metoprolol | Canada | Marketed | 2019 |
| MICAFUNGIN SODIUM FOR INJECTION50 mg / vial · Powder For Solution | Micafungin | Canada | Marketed | 2024 |
| MICAFUNGIN SODIUM FOR INJECTION100 mg / vial · Powder For Solution | Micafungin | Canada | Marketed | 2024 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 44 | 43 | 1 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Ranked by their number of medicines.